Analysts Expect Heska Corporation (HSKA) Will Announce Earnings of $0.39 Per Share
Wall Street brokerages expect that Heska Corporation (NASDAQ:HSKA) will post $0.39 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Heska Corporation’s earnings, with the lowest EPS estimate coming in at $0.38 and the highest estimate coming in at $0.40. Heska Corporation posted earnings of $0.45 per share in the same quarter last year, which would suggest a negative year over year growth rate of 13.3%. The business is scheduled to issue its next quarterly earnings report before the market opens on Thursday, November 2nd.
According to Zacks, analysts expect that Heska Corporation will report full year earnings of $2.01 per share for the current fiscal year, with EPS estimates ranging from $2.00 to $2.04. For the next financial year, analysts forecast that the business will report earnings of $2.10 per share, with EPS estimates ranging from $2.00 to $2.25. Zacks’ earnings per share averages are an average based on a survey of research analysts that cover Heska Corporation.
Heska Corporation (NASDAQ:HSKA) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported $0.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.07. The business had revenue of $34.30 million for the quarter, compared to the consensus estimate of $33.35 million. Heska Corporation had a net margin of 10.70% and a return on equity of 15.87%. The company’s revenue was up 14.3% compared to the same quarter last year. During the same period last year, the firm posted $0.35 earnings per share.
Several equities research analysts have commented on the stock. Canaccord Genuity assumed coverage on shares of Heska Corporation in a research report on Thursday, October 5th. They set a “buy” rating and a $115.00 target price on the stock. Zacks Investment Research lowered shares of Heska Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. BidaskClub lowered shares of Heska Corporation from a “buy” rating to a “hold” rating in a research report on Monday, August 14th. Benchmark Co. restated a “buy” rating and set a $120.00 target price (up from $106.00) on shares of Heska Corporation in a research report on Wednesday, August 9th. Finally, B. Riley restated a “neutral” rating and set a $96.50 target price on shares of Heska Corporation in a research report on Thursday, August 3rd. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $106.83.
Heska Corporation (HSKA) opened at 97.31 on Wednesday. The stock has a market capitalization of $703.16 million, a P/E ratio of 49.60 and a beta of 0.84. The firm’s 50-day moving average is $93.94 and its 200 day moving average is $97.99. Heska Corporation has a 12-month low of $46.51 and a 12-month high of $115.00.
In related news, CFO John Mcmahon sold 2,608 shares of the business’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $101.17, for a total value of $263,851.36. Following the sale, the chief financial officer now directly owns 193 shares in the company, valued at approximately $19,525.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Nancy Wisnewski sold 825 shares of the business’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $102.21, for a total transaction of $84,323.25. Following the completion of the sale, the executive vice president now owns 38,114 shares in the company, valued at $3,895,631.94. The disclosure for this sale can be found here. 14.70% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in HSKA. Mason Street Advisors LLC purchased a new stake in shares of Heska Corporation in the 1st quarter worth about $144,000. Envestnet Asset Management Inc. purchased a new stake in shares of Heska Corporation in the 1st quarter worth about $166,000. Victory Capital Management Inc. purchased a new stake in shares of Heska Corporation in the 1st quarter worth about $101,000. American International Group Inc. boosted its position in shares of Heska Corporation by 7.1% in the 1st quarter. American International Group Inc. now owns 3,754 shares of the medical research company’s stock worth $394,000 after buying an additional 248 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in shares of Heska Corporation by 627.2% in the 1st quarter. Alliancebernstein L.P. now owns 23,270 shares of the medical research company’s stock worth $2,443,000 after buying an additional 20,070 shares in the last quarter. Institutional investors and hedge funds own 80.47% of the company’s stock.
About Heska Corporation
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.